bullish
“Buy the Worst” Strategy into Year 3: What's on for 2022 to Beat the HSI?
673 Views30 Dec 2021 08:17
Our "Buy the Worst" strategy outperformed HSI by a massive 26.1pp YTD. For 2022, new names are Haidilao, Ali Health, Alibaba, Sands China and Xiaomi, based on YTD share price performance.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Rising
Osbert Tang, CFA
HK/China Equity Long-Short
- HK Tech Index Pressure Bleed into HSI Fresh Sell Zone21 Feb 2022
- Rising US Interest Rate: A Look at Which HK Blue Chips Are Less Vulnerable14 Feb 2022
- A Share Fizzle - HK Tech Bullish Base13 Jan 2022
- A Mid-Year Review of Our "Buy the Worst" Strategy: Outperformed HSI by 20.9pp12 Jul 2021
- A Review Of "Buy the Worst" Strategy in 2020 and Can It Beat the Hang Seng Index in 2021?30 Dec 2020
- "Buy the Worst" - A Simple Strategy to Beat the Hang Seng Index in 2020 and the Years to Come?23 Dec 2019
x